Extracorporeal hepatocyte-based therapy (Vital Therapies)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameExtracorporeal hepatocyte-based therapy (Vital Therapies)
Drug Alias NameELADExtracorporeal bio-artificial liverVTL-C3A
ClassificationBiologics
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsHepatitis, AlcoholicLiver Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVital Therapies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVital Therapies Inc
Active IndicationsN/A
Inactive IndicationsHepatitis, AlcoholicLiver Failure

Other Information

ATC CodeN/A
Related LinksN/A